Learn languages naturally with fresh, real content!

Popular Topics
Explore By Region
SOBRsafe raised $2M in a private stock and warrant sale to boost working capital.
SOBRsafe, Inc. (Nasdaq: SOBR) announced a $2 million private placement of common stock and warrants, priced at $1.55 per share, with proceeds to support working capital and general corporate purposes.
The company will issue 1,290,324 shares or pre-funded warrants, along with Series C and Series D warrants to purchase the same number of shares at $1.30 each, exercisable immediately.
Series C warrants expire five years after the resale registration statement becomes effective; Series D warrants expire 24 months later.
H.C. Wainwright & Co. is the exclusive placement agent.
The offering, expected to close around December 29, 2025, is subject to customary conditions and is limited to accredited investors under exemptions from SEC registration.
The company will file a resale registration statement for the securities.
SOBRsafe’s transdermal alcohol monitoring technology detects alcohol through skin emission in real time, offering non-invasive, passive screening for behavioral health, family law, and consumer applications.
Forward-looking statements include risks that actual results may differ.
SOBRsafe recaudó $2 millones en acciones privadas y una venta de garantías para aumentar el capital de trabajo.